<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Thu, 23 Apr 2026 12:33:17 -0400--><rss version="2.0">
    <channel>
        <title>NEXGEL, Inc. (NXGL) Press Releases</title>
        <link>https://ir.nexgel.com/news-events/press-releases/rss</link>
        <description></description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/nexgel/files/theme/images/logo-sm.png</url>
                <title>NEXGEL, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[NEXGEL New Strategic Partner, Sequence LifeScience™, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease Segment]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.nexgel.com/news-events/press-releases/detail/119/nexgel-new-strategic-partner-sequence-lifescience</link>
                <pubDate>Tue, 21 Apr 26 09:00:00 -0400</pubDate>
                <guid>https://ir.nexgel.com/news-events/press-releases/detail/119/nexgel-new-strategic-partner-sequence-lifescience</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.nexgel.com/news-events/press-releases/detail/118/nexgel-moves-forward-shareholder-update-call-to-discuss</link>
                <pubDate>Fri, 17 Apr 26 15:37:00 -0400</pubDate>
                <guid>https://ir.nexgel.com/news-events/press-releases/detail/118/nexgel-moves-forward-shareholder-update-call-to-discuss</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[NEXGEL Reschedules Shareholder Update Conference Call to April 23rd at 4:30 P.M. ET to Provide Update on Celularity Transaction]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.nexgel.com/news-events/press-releases/detail/117/nexgel-reschedules-shareholder-update-conference-call-to</link>
                <pubDate>Wed, 15 Apr 26 16:12:00 -0400</pubDate>
                <guid>https://ir.nexgel.com/news-events/press-releases/detail/117/nexgel-reschedules-shareholder-update-conference-call-to</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[NEXGEL Reschedules Shareholder Update Conference Call to April 15th at 4:30 P.M. ET to Provide Update on Celularity Transaction]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.nexgel.com/news-events/press-releases/detail/116/nexgel-reschedules-shareholder-update-conference-call-to</link>
                <pubDate>Wed, 08 Apr 26 16:05:00 -0400</pubDate>
                <guid>https://ir.nexgel.com/news-events/press-releases/detail/116/nexgel-reschedules-shareholder-update-conference-call-to</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[NEXGEL Reschedules 2025 Financial Results Conference Call to April 8th at 4:30 P.M. ET to Provide Shareholders with an Update on Its Previously Announced Transaction with Celularity]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.nexgel.com/news-events/press-releases/detail/115/nexgel-reschedules-2025-financial-results-conference-call</link>
                <pubDate>Tue, 31 Mar 26 16:12:00 -0400</pubDate>
                <guid>https://ir.nexgel.com/news-events/press-releases/detail/115/nexgel-reschedules-2025-financial-results-conference-call</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[NEXGEL to Report Fourth Quarter and Full Year 2025 Financial Results on March 31st]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.nexgel.com/news-events/press-releases/detail/114/nexgel-to-report-fourth-quarter-and-full-year-2025</link>
                <pubDate>Wed, 25 Mar 26 09:00:00 -0400</pubDate>
                <guid>https://ir.nexgel.com/news-events/press-releases/detail/114/nexgel-to-report-fourth-quarter-and-full-year-2025</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial Products]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.nexgel.com/news-events/press-releases/detail/113/nexgel-announces-consideration-terms-of-agreement-to</link>
                <pubDate>Thu, 12 Mar 26 08:45:00 -0400</pubDate>
                <guid>https://ir.nexgel.com/news-events/press-releases/detail/113/nexgel-announces-consideration-terms-of-agreement-to</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[NEXGEL Signs Definitive Agreement to License and Acquire Transformative Portfolio of Commercial-Stage Regenerative Biomaterial Products]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.nexgel.com/news-events/press-releases/detail/112/nexgel-signs-definitive-agreement-to-license-and-acquire</link>
                <pubDate>Tue, 10 Mar 26 08:45:00 -0400</pubDate>
                <guid>https://ir.nexgel.com/news-events/press-releases/detail/112/nexgel-signs-definitive-agreement-to-license-and-acquire</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[NEXGEL Announces Financing of $1.797 Million Relating to an Acquisition Targeted to Close in the First Quarter of 2026, Subject to the Completion of Due Diligence]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.nexgel.com/news-events/press-releases/detail/111/nexgel-announces-financing-of-1-797-million-relating-to-an</link>
                <pubDate>Tue, 10 Feb 26 09:00:00 -0500</pubDate>
                <guid>https://ir.nexgel.com/news-events/press-releases/detail/111/nexgel-announces-financing-of-1-797-million-relating-to-an</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[NexGelRx Receives Additional Investment from Eric Gruntfest of Diesis Holdings, LLC and Appoints Him as Board Observer and Strategic Advisor]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.nexgel.com/news-events/press-releases/detail/110/nexgelrx-receives-additional-investment-from-eric-gruntfest</link>
                <pubDate>Tue, 16 Dec 25 08:00:00 -0500</pubDate>
                <guid>https://ir.nexgel.com/news-events/press-releases/detail/110/nexgelrx-receives-additional-investment-from-eric-gruntfest</guid>
                                                                            </item>
            </channel>
</rss>